• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

武藏-1正向调节肝癌细胞的生长和增殖

[Musashi-1 positively regulates growth and proliferation of hepatoma cells ].

作者信息

Li Jie, Yan Kun, Yang Yi, Li Hua, Wang Zhidong, Xu Xin

机构信息

Department of General Surgery, Second Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, 710004.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2019 Dec 30;39(12):1436-1442. doi: 10.12122/j.issn.1673-4254.2019.12.07.

DOI:10.12122/j.issn.1673-4254.2019.12.07
PMID:31907147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6942989/
Abstract

OBJECTIVE

To investigate the regulatory role of Musashi-1 (MSI1) in the proliferation and growth of hepatocellular carcinoma (HCC) cells.

METHODS

We examined the expression of MSI1 in HCC and paired adjacent tissues from 24 patients using immunohistochemistry and Western blotting. A MSI1-expressing vector was constructed and stably transfected into HepG2 cells, and short hairpin RNAs (shRNAs) that targeted MSI1 mRNA were ligated into the vector and stably transfected in Huh7 cells. The effects of MSI1 overexpression and silencing on the proliferation, viability and cell cycle of HepG2 cells were investigated using flow cytometry or MTT assay. The expressions of PCNA, cyclin D1, APC and β-catenin in the HCC cells were detected with Western blotting.

RESULTS

MSI1 expression was significantly up-regulated in HCC tissues as compared with that in the adjacent tissues. Overexpression of MSI1 in HepG2 cells resulted in significantly enhanced cell growth ( < 0.01) and significantly reduced G0/G1 phase cells from (58.42±3.18)% to (40.67±1.22)% and increased S phase cells from (28.51± 1.93)% to (40.06±1.92)% ( < 0.01), causing also increases in the expressions of PCNA and Cyclin D1. Knockdown of MSI1 in Huh7 cells obviously inhibited the cell growth and caused cell cycle arrest at the G1/S phase ( < 0.01) with reduced protein expressions of PCNA and cyclin D1. Overexpression of MSI1 in HepG2 cells also down-regulated the expression of APC and up-regulated the expression of β-catenin protein, while MSI1 knockdown caused reverse changes in Huh7 cells.

CONCLUSIONS

MSI1 promotes the progression of HCC through positive modulation of cell growth and cell cycle the Wnt/β-catenin pathway.

摘要

目的

探讨Musashi-1(MSI1)在肝细胞癌(HCC)细胞增殖和生长中的调控作用。

方法

我们采用免疫组织化学和蛋白质印迹法检测了24例患者肝癌组织及配对癌旁组织中MSI1的表达。构建了表达MSI1的载体并稳定转染至HepG2细胞,将靶向MSI1 mRNA的短发夹RNA(shRNAs)连接到载体中并稳定转染至Huh7细胞。使用流式细胞术或MTT法研究MSI1过表达和沉默对HepG2细胞增殖、活力和细胞周期的影响。通过蛋白质印迹法检测肝癌细胞中PCNA、细胞周期蛋白D1、APC和β-连环蛋白的表达。

结果

与癌旁组织相比,肝癌组织中MSI1表达显著上调。HepG2细胞中MSI1过表达导致细胞生长显著增强(<0.01),G0/G1期细胞从(58.42±3.18)%显著减少至(40.67±1.22)%,S期细胞从(28.51±1.93)%增加至(40.06±1.92)%(<0.01),同时PCNA和细胞周期蛋白D1的表达也增加。Huh7细胞中MSI1敲低明显抑制细胞生长并导致细胞周期停滞在G1/S期(<0.01),PCNA和细胞周期蛋白D1的蛋白表达降低。HepG2细胞中MSI1过表达还下调了APC的表达并上调了β-连环蛋白的表达,而MSI1敲低在Huh7细胞中导致相反的变化。

结论

MSI1通过正向调节细胞生长和细胞周期以及Wnt/β-连环蛋白途径促进肝癌进展。

相似文献

1
[Musashi-1 positively regulates growth and proliferation of hepatoma cells ].武藏-1正向调节肝癌细胞的生长和增殖
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Dec 30;39(12):1436-1442. doi: 10.12122/j.issn.1673-4254.2019.12.07.
2
Musashi1 regulates survival of hepatoma cell lines by activation of Wnt signalling pathway.Musashi1通过激活Wnt信号通路调节肝癌细胞系的存活。
Liver Int. 2015 Mar;35(3):986-98. doi: 10.1111/liv.12458. Epub 2014 Jan 29.
3
Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.在宫颈癌中,Msi1通过靶向细胞周期检查点蛋白p21、p27和p53来促进肿瘤生长和细胞增殖。
Oncotarget. 2014 Nov 15;5(21):10870-85. doi: 10.18632/oncotarget.2539.
4
MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.微小RNA-19a、微小RNA-122和微小RNA-223受乙型肝炎病毒X蛋白的差异调节,并参与肝癌细胞的细胞增殖。
J Transl Med. 2016 May 5;14(1):122. doi: 10.1186/s12967-016-0888-7.
5
The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.沉默β-连环蛋白基因后对肝癌细胞系HepG2和SMMC-7721细胞周期及细胞周期蛋白B1和细胞周期蛋白C蛋白表达的影响
Hepatogastroenterology. 2012 Mar-Apr;59(114):515-8. doi: 10.5754/hge11534.
6
Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.转录因子MafB通过上调细胞周期蛋白D1促进肝癌细胞增殖。
Cell Physiol Biochem. 2016;39(2):700-8. doi: 10.1159/000445661. Epub 2016 Jul 25.
7
Knockdown of MSI1 inhibits the proliferation of human oral squamous cell carcinoma by inactivating STAT3 signaling.敲低 MSI1 通过使 STAT3 信号失活抑制人口腔鳞状细胞癌的增殖。
Int J Mol Med. 2019 Jul;44(1):115-124. doi: 10.3892/ijmm.2019.4181. Epub 2019 May 6.
8
A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.一种新型全反式维甲酸衍生物4-氨基-2-三氟甲基苯基维甲酸酯通过上调p53和ASPP1以及下调iASPP诱导G0/G1期细胞周期阻滞和凋亡,从而抑制人肝癌HepG2细胞的增殖。
Oncol Rep. 2016 Jul;36(1):333-41. doi: 10.3892/or.2016.4795. Epub 2016 May 9.
9
Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.特异性COX-2抑制剂美洛昔康可抑制人HepG2肝癌细胞的增殖并诱导其凋亡。
J Gastroenterol Hepatol. 2006 Dec;21(12):1814-20. doi: 10.1111/j.1440-1746.2006.04366.x.
10
Latexin exhibits tumor suppressor potential in hepatocellular carcinoma.Latexin在肝细胞癌中表现出肿瘤抑制潜力。
Oncol Rep. 2014 Mar;31(3):1364-72. doi: 10.3892/or.2014.2966. Epub 2014 Jan 8.

引用本文的文献

1
Exploring RNA binding proteins in hepatocellular carcinoma: insights into mechanisms and therapeutic potential.探索肝细胞癌中的RNA结合蛋白:对其机制及治疗潜力的见解
J Exp Clin Cancer Res. 2025 Apr 24;44(1):130. doi: 10.1186/s13046-025-03395-7.
2
Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells.Musashi-1调节细胞周期并赋予3/4组髓母细胞瘤细胞对顺铂治疗的抗性。
Hum Cell. 2023 Nov;36(6):2129-2139. doi: 10.1007/s13577-023-00954-y. Epub 2023 Jul 17.
3
The Emerging Role of Stress Granules in Hepatocellular Carcinoma.应激颗粒在肝细胞癌中的新兴作用。
Int J Mol Sci. 2021 Aug 30;22(17):9428. doi: 10.3390/ijms22179428.
4
Musashi1 Contribution to Glioblastoma Development via Regulation of a Network of DNA Replication, Cell Cycle and Division Genes.Musashi1通过调控DNA复制、细胞周期和分裂基因网络对胶质母细胞瘤发展的作用。
Cancers (Basel). 2021 Mar 24;13(7):1494. doi: 10.3390/cancers13071494.
5
Recent progress in treatment of hepatocellular carcinoma.肝细胞癌治疗的最新进展
Am J Cancer Res. 2020 Sep 1;10(9):2993-3036. eCollection 2020.

本文引用的文献

1
Sorafenib/MEK inhibitor combination inhibits tumor growth and the Wnt/β‑catenin pathway in xenograft models of hepatocellular carcinoma.索拉非尼/MEK 抑制剂联合抑制肝癌异种移植模型中的肿瘤生长和 Wnt/β-catenin 通路。
Int J Oncol. 2019 Mar;54(3):1123-1133. doi: 10.3892/ijo.2019.4693. Epub 2019 Jan 23.
2
Adoptive cell transfer therapy for hepatocellular carcinoma.过继细胞转移疗法治疗肝细胞癌。
Front Med. 2019 Feb;13(1):3-11. doi: 10.1007/s11684-019-0684-x. Epub 2019 Jan 18.
3
Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy.直接抗病毒治疗后 HCC 复发的分子机制。
Int J Mol Sci. 2018 Dec 22;20(1):49. doi: 10.3390/ijms20010049.
4
Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes.基于代谢网络的肝细胞癌分层揭示了三种不同的肿瘤亚型。
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11874-E11883. doi: 10.1073/pnas.1807305115. Epub 2018 Nov 27.
5
Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.木樨草素抑制 Musashi1 与 RNA 的结合并破坏神经胶质瘤细胞中的癌症表型。
RNA Biol. 2018;15(11):1420-1432. doi: 10.1080/15476286.2018.1539607. Epub 2018 Nov 18.
6
Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.癌易感性候选基因 2 的过表达抑制了肝癌细胞的进展。
J Cell Physiol. 2019 Jun;234(6):9008-9018. doi: 10.1002/jcp.27573. Epub 2018 Oct 26.
7
microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.miRNA-193a-5p 通过调控核仁纺锤体相关蛋白 1 的水平抑制肝癌发生。
Gastroenterology. 2018 Dec;155(6):1951-1966.e26. doi: 10.1053/j.gastro.2018.08.032. Epub 2018 Aug 27.
8
Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers.肝细胞癌:病因、进展机制及生物标志物
Curr Chem Genom Transl Med. 2018 Jun 29;12:9-26. doi: 10.2174/2213988501812010009. eCollection 2018.
9
Functional Polymorphism in the Gene Promoter Confers a Decreased Risk of Lung Cancer in Chinese by Reducing Expression.基因启动子中的功能性多态性通过降低表达降低中国人群患肺癌的风险。
Curr Genomics. 2018 Aug;19(5):375-383. doi: 10.2174/1389202919666171128151544.
10
Heat Shock Protein 90α-Dependent B-Cell-2-Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto-Oncogene c-MYC mRNA Stability.热休克蛋白 90α 依赖性 B 细胞相关转录因子 1 通过调节原癌基因 c-MYC mRNA 稳定性促进肝癌增殖。
Hepatology. 2019 Apr;69(4):1564-1581. doi: 10.1002/hep.30172. Epub 2018 Oct 4.